Computational morphogenesis - Embryogenesis, cancer research and digital pathology

[1]  Peter Hufnagl,et al.  A general framework dedicated to computational morphogenesis Part II - Knowledge representation and architecture , 2018, Biosyst..

[2]  Peter Hufnagl,et al.  A general framework dedicated to computational morphogenesis Part I - Constitutive equations , 2018, Biosyst..

[3]  Ruo-Pan Huang,et al.  New Insights into the Tumor Microenvironment Utilizing Protein Array Technology , 2018, International journal of molecular sciences.

[4]  A. Veronese,et al.  Epigenetics and MicroRNAs in Cancer , 2018, International journal of molecular sciences.

[5]  M. Jackson,et al.  Targeting Pancreatic Cancer Cell Plasticity: The Latest in Therapeutics , 2018, Cancers.

[6]  Karim C. Abbaspour,et al.  A Guideline for Successful Calibration and Uncertainty Analysis for Soil and Water Assessment: A Review of Papers from the 2016 International SWAT Conference , 2017 .

[7]  A. Pession,et al.  Human Cancer Cells Signal Their Competitive Fitness Through MYC Activity , 2017, Scientific Reports.

[8]  J. Routy,et al.  The Th17 Lineage: From Barrier Surfaces Homeostasis to Autoimmunity, Cancer, and HIV-1 Pathogenesis , 2017, Viruses.

[9]  Coralia Cartis,et al.  Calibrating climate models using inverse methods: case studies with HadAM3, HadAM3P and HadCM3 , 2017 .

[10]  P. de Vos,et al.  Uterine NK cells and macrophages in pregnancy. , 2017, Placenta.

[11]  R. Lechler,et al.  An Atlas of Human Regulatory T Helper-like Cells Reveals Features of Th2-like Tregs that Support a Tumorigenic Environment , 2017, Cell reports.

[12]  M. Veldhoen,et al.  Cellular Stress in the Context of an Inflammatory Environment Supports TGF-β-Independent T Helper-17 Differentiation , 2017, Cell reports.

[13]  C. Balch,et al.  The Epigenomics of Embryonic Pathway Signaling in Colorectal Cancer , 2017, Front. Pharmacol..

[14]  J. Chavez,et al.  The role of anti-PD-1 and anti-PD-L1 agents in the treatment of diffuse large B-cell lymphoma: The future is now. , 2017, Critical reviews in oncology/hematology.

[15]  W. Seeger,et al.  Redirecting tumor-associated macrophages to become tumoricidal effectors as a novel strategy for cancer therapy , 2017, Oncotarget.

[16]  Dong Li,et al.  IL-35 induces N2 phenotype of neutrophils to promote tumor growth , 2017, Oncotarget.

[17]  C. Zahnow,et al.  Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non-Small Cell Lung Cancer. , 2017, Cancer discovery.

[18]  Wei Xiong,et al.  Role of tumor microenvironment in tumorigenesis , 2017, Journal of Cancer.

[19]  N. McGranahan,et al.  Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future , 2017, Cell.

[20]  M. DePamphilis,et al.  Links between DNA Replication, Stem Cells and Cancer , 2017, Genes.

[21]  Nadine Peyriéras,et al.  A cell-based computational model of early embryogenesis coupling mechanical behaviour and gene regulation , 2017, Nature Communications.

[22]  Michael C. Schmid,et al.  Macrophages as Key Drivers of Cancer Progression and Metastasis , 2017, Mediators of inflammation.

[23]  C. Crum,et al.  Serous tubal intraepithelial neoplasia: the concept and its application , 2017, Modern Pathology.

[24]  D. Segarnick.  "PD-L1/PD-1 Inhibitors and Beyond: The Evolving Role of Checkpoint Inhibitors and Biomarkers in Cancer Immunotherapy" , 2017 .

[25]  Darren Gilmour,et al.  From morphogen to morphogenesis and back , 2017, Nature.

[26]  T. Das.  Deciphering the Cancer Puzzle: Cancer Stem Cells Being the Pivotal Piece , 2017 .

[27]  Saroj Singh,et al.  Initiative action of tumor-associated macrophage during tumor metastasis , 2017, Biochimie open.

[28]  P. Siregar,et al.  Cross-Fertilization between Computational Morphogenesis and Digital Pathology , 2016 .

[29]  Norbert Meyer,et al.  Interleukins (from IL-1 to IL-38), interferons, transforming growth factor β, and TNF-α: Receptors, functions, and roles in diseases. , 2016, The Journal of allergy and clinical immunology.

[30]  A. Tzankov,et al.  The immune system and cancer evasion strategies: therapeutic concepts , 2016, Journal of internal medicine.

[31]  R. Gillies,et al.  Exploiting evolutionary principles to prolong tumor control in preclinical models of breast cancer , 2016, Science Translational Medicine.

[32]  S. Suijkerbuijk,et al.  Cell Competition Drives the Growth of Intestinal Adenomas in Drosophila , 2016, Current Biology.

[33]  Joon-Oh Park,et al.  The Impact of PD-L1 Expression in Patients with Metastatic GEP-NETs , 2016, Journal of Cancer.

[34]  Kou-Juey Wu,et al.  Hypoxia, Epithelial-Mesenchymal Transition, and TET-Mediated Epigenetic Changes , 2016, Journal of clinical medicine.

[35]  E. Buchbinder,et al.  CTLA-4 and PD-1 Pathways , 2016, American journal of clinical oncology.

[36]  Alan Ashworth,et al.  BRCAness revisited , 2016, Nature Reviews Cancer.

[37]  M. Nykter,et al.  Feature-based analysis of mouse prostatic intraepithelial neoplasia in histological tissue sections , 2016, Journal of pathology informatics.

[38]  S. Dey,et al.  Neutrophils Oppose Uterine Epithelial Carcinogenesis via Debridement of Hypoxic Tumor Cells. , 2015, Cancer cell.

[39]  Qian Zhang,et al.  Classification of Ultra-High Resolution Orthophotos Combined with DSM Using a Dual Morphological Top Hat Profile , 2015, Remote. Sens..

[40]  P. Minoo,et al.  PTEN regulates lung endodermal morphogenesis through MEK/ERK pathway. , 2015, Developmental biology.

[41]  Jia Zhang,et al.  Regulation of epithelial-mesenchymal transition by tumor-associated macrophages in cancer. , 2015, American journal of translational research.

[42]  D. Voehringer,et al.  The microbiota regulates type 2 immunity through RORγt+ T cells , 2015, Science.

[43]  Olaf Hellwich,et al.  A review of graph-based methods for image analysis in digital histopathology , 2015 .

[44]  Zheying Sun.  The General Information of the Tumor Suppressor Gene p53 and the Protein p53 , 2015 .

[45]  Lei Chen,et al.  Wnt and Notch signaling pathway involved in wound healing by targeting c-Myc and Hes1 separately , 2015, Stem Cell Research & Therapy.

[46]  Navid Farahani,et al.  whole slide imaging in pathology: advantages, limitations, and emerging perspectives , 2015 .

[47]  Geoffrey E. Hinton,et al.  Deep Learning , 2015, Nature.

[48]  T. Chan,et al.  Therapeutic targeting of tumor suppressor genes , 2015, Cancer.

[49]  Erik Sahai,et al.  Intravital Imaging Reveals How BRAF Inhibition Generates Drug-Tolerant Microenvironments with High Integrin β1/FAK Signaling , 2015, Cancer cell.

[50]  J. Strominger,et al.  Immune mechanisms at the maternal-fetal interface: perspectives and challenges , 2015, Nature Immunology.

[51]  F. Annunziato,et al.  The 3 major types of innate and adaptive cell-mediated effector immunity. , 2015, The Journal of allergy and clinical immunology.

[52]  M. Höckel.  Morphogenetic fields of embryonic development in locoregional cancer spread. , 2015, The Lancet. Oncology.

[53]  Isaac M. Adjei,et al.  Modulation of the Tumor Microenvironment for Cancer Treatment: A Biomaterials Approach , 2015, Journal of functional biomaterials.

[54]  Marc Ladanyi,et al.  Synovial sarcoma: recent discoveries as a roadmap to new avenues for therapy. , 2015, Cancer discovery.

[55]  M. Nowak,et al.  Only three driver gene mutations are required for the development of lung and colorectal cancers , 2014, Proceedings of the National Academy of Sciences.

[56]  Michael Levin,et al.  Molecular bioelectricity: how endogenous voltage potentials control cell behavior and instruct pattern regulation in vivo , 2014, Molecular biology of the cell.

[57]  A. Lo,et al.  Unintended consequences of expensive cancer therapeutics—the pursuit of marginal indications and a me-too mentality that stifles innovation and creativity: the John Conley Lecture. , 2014, JAMA otolaryngology-- head & neck surgery.

[58]  Jing Wang,et al.  Insulin-like growth factor (IGF) signaling in tumorigenesis and the development of cancer drug resistance , 2014, Genes & diseases.

[59]  K. Cadwell,et al.  An enteric virus can replace the beneficial function of commensal bacteria , 2014, Nature.

[60]  K. Bendix,et al.  High intratumoral macrophage content is an adverse prognostic feature in anaplastic large cell lymphoma , 2014, Histopathology.

[61]  M. Levin,et al.  Endogenous Voltage Potentials and the Microenvironment: Bioelectric Signals that Reveal, Induce and Normalize Cancer. , 2014, Journal of clinical & experimental oncology.

[62]  A. Szilágyi,et al.  Placental Protein 13 (PP13) – A Placental Immunoregulatory Galectin Protecting Pregnancy , 2014, Front. Immunol..

[63]  F. Bushman,et al.  Virus-helminth coinfection reveals a microbiota-independent mechanism of immunomodulation , 2014, Science.

[64]  Jiang Yao,et al.  Bending of the looping heart: differential growth revisited. , 2014, Journal of biomechanical engineering.

[65]  Brendan J. Frey,et al.  Deep learning of the tissue-regulated splicing code , 2014, Bioinform..

[66]  D. Neuberg,et al.  Emergence, involution, and progression to carcinoma of mutant clones in normal endometrial tissues. , 2014, Cancer research.

[67]  G. Dotto.  Multifocal epithelial tumors and field cancerization: stroma as a primary determinant. , 2014, The Journal of clinical investigation.

[68]  A. Luster,et al.  Chemokines and chemokine receptors: positioning cells for host defense and immunity. , 2014, Annual review of immunology.

[69]  A. Krešo,et al.  Evolution of the cancer stem cell model. , 2014, Cell stem cell.

[70]  D. Kabelitz,et al.  When neutrophils meet T cells: Beginnings of a tumultuous relationship with underappreciated potential , 2014, European journal of immunology.

[71]  Bipasha Bose,et al.  Stem Cell versus Cancer and Cancer Stem Cell: Intricate Balance Decides Their Respective Usefulness or Harmfulness in the Biological System , 2014 .

[72]  Gary D Bader,et al.  Epigenomic alterations define lethal CIMP-positive ependymomas of infancy , 2014, Nature.

[73]  Dajin Li,et al.  Embryonic Trophoblasts Induce Decidual Regulatory T Cell Differentiation and Maternal–Fetal Tolerance through Thymic Stromal Lymphopoietin Instructing Dendritic Cells , 2014, The Journal of Immunology.

[74]  E. Cuyás,et al.  Xenopatients 2.0: Reprogramming the epigenetic landscapes of patient-derived cancer genomes , 2014, Cell cycle.

[75]  S. Lowe,et al.  A New Development in Senescence , 2013, Cell.

[76]  R. Sturmey,et al.  Parallels between embryo and cancer cell metabolism. , 2013, Biochemical Society transactions.

[77]  O. Casanovas,et al.  Anti‐angiogenesis and metastasis: a tumour and stromal cell alliance , 2013, Journal of internal medicine.

[78]  Hans G Othmer,et al.  A Hybrid Model of Tumor–Stromal Interactions in Breast Cancer , 2013, Bulletin of Mathematical Biology.

[79]  Lev V. Beloussov,et al.  Morphogenesis as a macroscopic self-organizing process , 2012, Biosyst..

[80]  Abir U. Igamberdiev,et al.  Biomechanical and coherent phenomena in morphogenetic relaxation processes , 2012, Biosyst..

[81]  Michael Levin,et al.  Morphogenetic fields in embryogenesis, regeneration, and cancer: Non-local control of complex patterning , 2012, Biosyst..

[82]  Yukio-Pegio Gunji,et al.  Sociality of an agent during morphogenetic canalization: Asynchronous updating with potential resonance , 2012, Biosyst..

[83]  Giulio Gabbiani,et al.  The role of the myofibroblast in tumor stroma remodeling , 2012, Cell adhesion & migration.

[84]  Karolina Palucka,et al.  Cancer immunotherapy via dendritic cells , 2012, Nature Reviews Cancer.

[85]  D. Richel,et al.  The developing cancer stem-cell model: clinical challenges and opportunities. , 2012, The Lancet. Oncology.

[86]  Z. Werb,et al.  The extracellular matrix: A dynamic niche in cancer progression , 2012, The Journal of cell biology.

[87]  T. Wynn,et al.  Protective and pathogenic functions of macrophage subsets , 2011, Nature Reviews Immunology.

[88]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[89]  William C Hines,et al.  Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression , 2011, Nature Medicine.

[90]  F. C. Pan,et al.  Pancreas organogenesis: From bud to plexus to gland , 2011, Developmental dynamics : an official publication of the American Association of Anatomists.

[91]  A. Berns,et al.  A functional role for tumor cell heterogeneity in a mouse model of small cell lung cancer. , 2011, Cancer cell.

[92]  J. Galon,et al.  Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer. , 2011, Cancer research.

[93]  N. Carter,et al.  Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development , 2011, Cell.

[94]  Rafael Sirera,et al.  The Role of Tumor Stroma in Cancer Progression and Prognosis: Emphasis on Carcinoma-Associated Fibroblasts and Non-small Cell Lung Cancer , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[95]  Joseph C. Wu,et al.  Tumorigenicity of pluripotent stem cells: biological insights from molecular imaging , 2010, Journal of The Royal Society Interface.

[96]  F. Costantini,et al.  Patterning a complex organ: branching morphogenesis and nephron segmentation in kidney development. , 2010, Developmental cell.

[97]  L. Mincheva-Nilsson,et al.  REVIEW ARTICLE: The Role of Placental Exosomes in Reproduction , 2010, American journal of reproductive immunology.

[98]  Véronique Duboc,et al.  Building limb morphology through integration of signalling modules. , 2009, Current opinion in genetics & development.

[99]  Cristina M. Tato,et al.  IL-27 Blocks RORc Expression to Inhibit Lineage Commitment of Th17 Cells , 2009, The Journal of Immunology.

[100]  J. Strominger,et al.  T cell apoptosis at the maternal–fetal interface in early human pregnancy, involvement of galectin-1 , 2008, Proceedings of the National Academy of Sciences.

[101]  C Sonnenschein,et al.  On physicalism and Downward Causation in Developmental and Cancer Biology , 2008, Acta biotheoretica.

[102]  Guido Kroemer,et al.  Autophagy in the Pathogenesis of Disease , 2008, Cell.

[103]  T. Mak,et al.  Pten controls lung morphogenesis, bronchioalveolar stem cells, and onset of lung adenocarcinomas in mice. , 2007, The Journal of clinical investigation.

[104]  Anirban Datta,et al.  PTEN-Mediated Apical Segregation of Phosphoinositides Controls Epithelial Morphogenesis through Cdc42 , 2007, Cell.

[105]  Salvatore Torquato,et al.  Modeling the effects of vasculature evolution on early brain tumor growth. , 2006, Journal of theoretical biology.

[106]  Alissa M. Weaver,et al.  Tumor Morphology and Phenotypic Evolution Driven by Selective Pressure from the Microenvironment , 2006, Cell.

[107]  K. Sylvester,et al.  Repair and regeneration: opportunities for carcinogenesis from tissue stem cells , 2006, Journal of cellular and molecular medicine.

[108]  C. Sonnenschein,et al.  Stromal regulation of neoplastic development: age-dependent normalization of neoplastic mammary cells by mammary stroma. , 2005, The American journal of pathology.

[109]  T. Okazaki,et al.  Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4 , 2005, Nature Immunology.

[110]  Bart Landuyt,et al.  Vascular Endothelial Growth Factor and Angiogenesis , 2004, Pharmacological Reviews.

[111]  Y. Maru.  Molecular Biology of Chronic Myeloid Leukemia , 2001, International journal of hematology.

[112]  B. Hogan,et al.  Bmp4 and Fgf10 play opposing roles during lung bud morphogenesis. , 2000, Development.

[113]  P. Morel,et al.  Crossregulation between T helper cell (Th)1 and Th2: inhibition of Th2 proliferation by IFN-gamma involves interference with IL-1. , 1997, Journal of immunology.

[114]  C. Ries,et al.  Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy. , 2017, Journal for immunotherapy of cancer.

[115]  Andrew Zisserman,et al.  Detecting overlapping instances in microscopy images using extremal region trees , 2016, Medical Image Anal..

[116]  W. Grizzle,et al.  Exosomes: a novel pathway of local and distant intercellular communication that facilitates the growth and metastasis of neoplastic lesions. , 2014, The American journal of pathology.

[117]  S. Verbruggen,et al.  Anti-inflammatory M2, but not pro-inflammatory M1 macrophages promote angiogenesis in vivo , 2013, Angiogenesis.

[118]  S. Strom,et al.  Frequent aneuploidy among normal human hepatocytes. , 2012, Gastroenterology.

[119]  A. Stembalska,et al.  Cancer stem cells: the theory and perspectives in cancer therapy , 2010, Journal of Applied Genetics.

[120]  Polly Matzinger,et al.  Friendly and dangerous signals: is the tissue in control? , 2007, Nature Immunology.

[121]  R. Hruban,et al.  Precancer: a conceptual working definition -- results of a Consensus Conference. , 2006, Cancer detection and prevention.

[122]  Cigdem Demir,et al.  The cell graphs of cancer , 2004, ISMB/ECCB.

[123]  G. Mor,et al.  First trimester trophoblast cells secrete Fas ligand which induces immune cell apoptosis. , 2004, Molecular human reproduction.

[124]  Lewis Wolpert,et al.  Principles of Development , 1997 .